DE2952592A1 - MANUFACTURE OF MEDICINAL PRODUCTS AND MICRO-ORGANISM DETACHING AGENTS - Google Patents

Description

Manufacture of medicines and products for rendering harmless Microorganisms

The invention relates to a method for the production of medicaments and of Means for rendering microorganisms harmless by physical means, and is essentially characterized in that a substrate in the static Magnetic field, which is formed between two unlike magnetic poles, is irradiated with electromagnetic waves.

As has been found, it is possible to have harmful or undesirable microorganisms like bacteria, protozoa, fungi and viruses in biological and non-biological Kill systems, or at least deactivate them until they are harmless, by irradiated substrate (carrier substance) according to the invention lets act on them.

The starting point of the invention was the following observation:

Long-term toxoplasmosis patients with a positive Sabin-Feldmann test were im Three to four days apart, two to three injections of an isotonic Administered saline, which, as described below, irradiated in a static magnetic field with electromagnetic waves (low frequency) had been.

The Sabin-Feldmann test repeated about two weeks after the first injection was then negative and the subjective and objective symptoms of the disease remained permanently absent.

The drug effective against toxoplasmosis was prepared as follows been:

Two permanent bar magnets Type 108 ^ 6700 OXIT 300 K-369720 der Thyssen Edelstahlwerke AG built so that the north pole of one magnet and the south pole of the other magnet at an effective distance of 24 cm.

130027/07 (U

opposed that both magnetic bars had a common longitudinal axis.

The magnets were never from a magnet holder that could be swiveled through 360 held magnetizable material, the foot of such a magnet holder, designed as a sliding block, in the guide rail of a displacement device by means of a threaded spindle was relatively displaceable against the other foot.

A holding device was located in the middle between the two magnetic poles non-magnetizable material.

After inserting a glass ampoule containing a sterile isotonic saline solution in the holding device at the level of the magnetic poles, the ampoule was irradiated with a transmitter designed as a measuring transmitter so that the transmitter, its Output power was 1.5 W, brought as close as possible to the ampoule and operated perpendicular to the magnetic field for 15 to 20 seconds.

Frequencies were found to be particularly effective for the treatment of tcxoplasmosis when irradiating the substrate, which, in addition to an isotonic saline solution, also contains a Ringer's solution or another physiologically harmless solution can be found the frequency 14584 s ~ and 14596 s ~.

The isotonic one irradiated with electromagnetic radiation in a magnetic field Saline was then injected immediately after her irradiation.

However, the symptoms of toxoplasmosis were also remedied or alleviated and other disease states achieved if the irradiated agent has not been used until days after its preparation, but for which purpose the The prerequisite is that the irradiated agent is no further stronger technical may be exposed to magnetic or electromagnetic interference fields.

The frequency of electromagnetic radiation used to make the drug or, in general, the means for combating microorganisms depends on the type of microorganism and is generally not on the low

130Ö2Y / 07CU

the frequency range, as shown in the example, is limited. the effective frequencies are to be determined by a specialist on a case-by-case basis, likewise the optimal coordination between the strength of the applied static magnetic field and the energy of the electromagnetic alternating field.

The effect of the magnetic field can be caused by the fact that the magnetic field is generated by one or more permanent magnets (claim 2) or by one or more electromagnets (claim 3).

The strength of the magnetic field can be changed by changing the distance between the magnetic poles and / or adjusted to the desired size by changing the current intensity become (ASnspnuch 4).

The electromagnetic radiation can be perpendicular or parallel or oblique to the field lines of the magnetic field are radiated. (Claims 5 and 6).

The frequency of the radiated electromagnetic alternating field is preferably in the low frequency range (claim 7).

The energy of the electromagnetic radiation acting on the substrate can set by the transmission power of the transmitter for the electromagnetic radiation and / or by the distance of the transmitter from the substrate to be irradiated be (claim 8).

Solids, liquids and gases can be used as substrate, whereby During the irradiation the liquid or the gas in a vessel made of non-magnetizable)! Material, preferably glass, is included (claim 9).

If a metal disk is used as the solid body, it is particularly suitable one made of copper or iron (claim 10).

In the case of the use of liquids as substrates are particularly to call mineral solutions and brine (claim 11).

130027/0704

j The use of the medicinal products manufactured according to the claimed process

'tel is not restricted.

Liquid irradiated substrates (inert substances) can be injected. she

■ can also be used for bathrooms.

When using irradiated metal disks (carrier substances) externally,

this happens through direct long-term skin contact, preferably to the Acupuncture points.

j Carrier substances produced according to the invention are also capable of their Effect on those not exposed to electromagnetic radiation in a magnetic field; Transfer substrates. This creates a secondary substance (secondary product) manufactured. This is done by bringing previously unirradiated substrate in the magnetic field as close as possible to the carrier substance (claim

The carrier substances not only act on microorganisms in the human body, but also to those in other areas.

You can therefore z. B. also for disinfection purposes, and also to food to think is to be used.

130027/0704 ORIGINAL INSPECTED

Claims (16)

PATENT ADVOCATE DR.-ING. LOTTERHOS MM PRANKPURT (MAIN) 1 -η LICHTENSTEINSTRASSE 3 j NAChCi. ; - iCHTJ TELSPRECHER: (0611) 655081 'TELEGRAMS: LOMO6APATENT LANDESZENTRALBANK »007148 POSTSCHECK-ACCOUNT FFM. 1887-808 I / G FRANKFURT (MAIN) 1 Werner Kropp Bogenstraße 28 6751 Trippstadt patent claims 1. Process for the production of pharmaceuticals and of agents for rendering harmless of microorganisms, marked by the action of a magnetic and an electromagnetic field a substrate (carrier substance) to be used as a drug or agent to render microorganisms harmless, placing the substrate in the static magnetic field between two dissimilar Magnetic poles is irradiated with electromagnetic waves. 2. The method according to claim 1, characterized in that the Einw.i rkung of the magnetic field is caused by the fact that the magnetic field is generated by one or more permanent magnets. 3. The method according to claim 1, characterized in that the action of the magnetic field is caused by the fact that the magnetic field is generated by one or more electromagnets. 4. The method according to any one of claims 2 or 3, characterized in that the magnetic field strength is set to the desired size by changing the distance between the magnetic poles and / or by changing the current intensity. 130027/0704 ORIGINAL INSPECTED ■ 5. The method according to any one of claims 1 to 4, characterized in that , the electromagnetic radiation is radiated perpendicular to the magnetic field. '< 6. The method according to any one of claims 1 to M, characterized in that; the electromagnetic radiation parallel or oblique to the field lines of the '. Magnetic field is irradiated. Ϊ 7. The method according to claim 5 or 6, characterized in that the Frej frequency of the radiated electromagnetic alternating field, preferably in the low : the frequency range is. ; 8. The method according to any one of claims 5 to 7, characterized in that the energy of the electromagnetic radiation acting on the substrate : by the transmitting power of the transmitter for the electromagnetic radiation and / or by the distance of the transmitter from the substrate to be irradiated. ; will provide. 9. The method according to one or more of claims 1 to 8, characterized in that that a solid, a liquid or a gas is used as a substrate, the liquid or the gas in one during the irradiation Vessel made of non-magnetizable material, preferably glass, is included. 10. The method according to claim 9, characterized by using a metal disc, in particular made of copper, iron or a metal alloy, as a solid substrate. 11. The method according to claim 9, characterized by the use of "on mineral solutions, especially isotonic saline solution or Ringer's solution, or ι of brines, especially copper, silver and gold, as liquid Substrates. 12. Medicaments consisting of or containing one according to one of the claims 1 to 11 irradiated substrate (carrier substance) 130027/0704 13. Agents for rendering microorganisms harmless, consisting of or containing a substrate (carrier substance) irradiated according to one of claims 1 to 11 . 14. Process for the production of a secondary product, identified by a permanent .. ^ h, that a substrate in the magnetic field is brought as close as possible to a carrier substance produced according to one of claims 1 to 11. 15. Medicaments consisting of or containing a according to claim 14 manufactured secondary product. 16. Agent for rendering microorganisms harmless, consisting of a or containing a secondary product produced according to claim 14. 130027/070 /,